DHCR7 and bladder transitional cell carcinoma: Patients with high DHCR7 expression and low TMB demonstrated the poorest survival outcomes, while those with low DHCR7 expression and high TMB had the best outcomes, highlighting the prognostic significance of integrating DHCR7 expression and TMB in BLCA.